Januvia (sitagliptin) is now approved for monotherapy for type 2 diabetes

Januvia (sitagliptin) is now approved for monotherapy for type 2 diabetes in Canada....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login